Radcliffe Capital Management’s Biotech Acquisition Company Class A Ordinary Shares BIOT Stock Holding History

Radcliffe Capital Management’s Portfolio BIOT Stock Details BIOT Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell
2022 Q4	$4.61M	Hold
2022 Q3	$4.53M	Buy
2022 Q2	$4.02M	Hold
2022 Q1	$4M	Hold
2021 Q4	$3.99M	Hold
2021 Q3	$3.95M	Hold
2021 Q2	$3.92M	Buy